NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma
BOULDER, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) — Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology,…
Related Articles
HEALWELL to Acquire Orion Health, Creating a Global Market Leader in Healthcare Data Interoperability & Artificial Intelligence, and Launches $50Â Million Bought Deal Financing
HEALWELL AI has entered into an agreement to acquire 100% of the shares of Auckland, New Zealand based Orion Health Holdings Limited (âOrion Healthâ), a…
Conflict of Interest (COI)
An overview of ASCO’s policies and safeguards for relationships with companies, including frequently asked questions and editorials from ASCO’s senior staff.
Dysfunctional Giants: GM Joe Schoen’s reported handling of veteran player’s release one of many puzzling moves – CBSSports.com
Schoen’s handling of Nick McCloud raised eyebrows
When to Stay or Leave Your Physician Job – FREE Webinar
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the…
A Structural Description of Biases That Generate Immortal Time – PubMed
Immortal time may arise in survival analyses when individuals are assigned to treatment strategies based on post-eligibility information or selected based on post-assignment eligibility criteria.…
Will Zuck end censorship on Meta? The move away from Fact-checking to Community Notes
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 500+ Peer Reviewed papers,…
What Do Recent Clinical Trials Reveal About Biomarkers for Adjuvant Treatment in Localized RCC, and Whatâs Still Missing?
Among patients with high-risk localized renal cell carcinoma, recurrence rates range from 40% to 50% after partial or radical nephrectomy, establishing a critical need for…
A genomics learning framework for undergraduates
Genomics is an increasingly important part of biology research. However, educating undergraduates in genomics is not yet a standard part of life sciences curricula. We…
New drug hope for prostate cancer patients – Oncology Today
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and…
